New Korean Biotech ‘Control Tower’, Precision Med Committee To Spur R&D
This article was originally published in PharmAsia News
Executive Summary
South Korea will further support the biotech industry by setting up a ‘control tower’ designed to hone government policies and resolve industry concerns. The government will also form a state and private sector committee to speed up R&D in precision medicine, while injecting around $47.4m into R&D projects involving biomedical technology over the next five years.